Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development of Diabetic nephropathy (DN) leading to End Stage Renal Disease. Hence a better understanding of the factors affecting kidney disease progression in T1D is urgently needed. In recent years microRNAs have emerged as important post-transcriptional regulators of gene expression in many different health conditions. We hypothesized that urinary microRNA profile of patients will differ in the different stages of diabetic renal disease. METHODS AND FINDINGS: We studied urine microRNA profiles with qPCR in 40 T1D with >20 year follow up 10 who never developed renal disease (N) matched against 10 patients who went on to develop overt nephropathy (DN), 10 patients with intermittent microalbuminuria (IMA) matched against 10 patients with persistent (PMA) microalbuminuria. A Bayesian procedure was used to normalize and convert raw signals to expression ratios. We applied formal statistical techniques to translate fold changes to profiles of microRNA targets which were then used to make inferences about biological pathways in the Gene Ontology and REACTOME structured vocabularies. A total of 27 microRNAs were found to be present at significantly different levels in different stages of untreated nephropathy. These microRNAs mapped to overlapping pathways pertaining to growth factor signaling and renal fibrosis known to be targeted in diabetic kidney disease. CONCLUSIONS: Urinary microRNA profiles differ across the different stages of diabetic nephropathy. Previous work using experimental, clinical chemistry or biopsy samples has demonstrated differential expression of many of these microRNAs in a variety of chronic renal conditions and diabetes. Combining expression ratios of microRNAs with formal inferences about their predicted mRNA targets and associated biological pathways may yield useful markers for early diagnosis and risk stratification of DN in T1D by inferring the alteration of renal molecular processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886 · cited 1×
“interfering with protein synthesis by inducing mRNA degradation or repressing translation [5,6].”
BackgroundJohn, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796 · cited 1×
“To infer putative targets of differentially expressed miRNAs we utilized three different algorithms: miRanda (release August 2010) [20], TargetSCan (release 6, November 2011) [21] and miRDB (version 4.”
MethodThe BUGS project: evolution, critique and future directions
Lunn, D., Spiegelhalter, D., Thomas, A., & Best, N. (2009) · Statistics in Medicine · doi:10.1002/sim.3680 · Cited by 1,876
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890
Reactome knowledgebase of human biological pathways and processes
Matthews, L., Gopinath, G., Gillespie, M., Caudy, M., Croft, D., de Bono, B., Garapati, P., Hemish, J., Hermjakob, H., Jassal, B., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn863 · Cited by 873 · cited 5×
“The results from Gene Ontology (GO) analysis (Datasets S2, S3, S4, S5) were consistent with REACTOME, and also identified enrichment of terms relating to nitrogen compound metabolism, Golgi/membrane/ER vesicle recycling, ubiquitin-dependent degradation, cell adhesion and cell adhesion.”
MethodInfluentialOlmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Real-time PCR quantification of precursor and mature microRNA
Schmittgen, T. D., Lee, E. J., Jiang, J., Sarkar, A., Yang, L., Elton, T. S., & Chen, C. (2008) · Methods · doi:10.1016/j.ymeth.2007.09.006 · Cited by 616 · cited 1×
“Secondly, the difference in the expression level of the spiked in (UniSp3) control was used to calibrate relative fold changes (FC) by the Delta-Delta method [14,15] as: FC = 2, where DDCq =DCq(miRNA) – DCq(UniSp3).”
Method
Research works printed but not linked: 55
- ME Molitch, 2004, Nephropathy in diabetes, Diabetes Care, 27, S79, 10.2337/diacare.27.2007.S79 · DOI · Paper page
- YS Kanwar, 2011, A glimpse of various pathogenetic mechanisms of diabetic nephropathy, Annu Rev Pathol, 6, 395, 10.1146/annurev.pathol.4.110807.092150 · DOI · Paper page
- RW Carthew, 2009, Origins and Mechanisms of miRNAs and siRNAs, Cell, 136, 642, 10.1016/j.cell.2009.01.035 · DOI · Paper page
- RC Lee, 2001, An extensive class of small RNAs in Caenorhabditis elegans, Science, 294, 862, 10.1126/science.1065329 · DOI · Paper page
- DP Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
- P Kantharidis, 2011, Diabetes complications: the microRNA perspective, Diabetes, 60, 1832, 10.2337/db11-0082 · DOI · Paper page
- K Bhatt, 2011, microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles, Am J Physiol Renal Physiol, 300, F602, 10.1152/ajprenal.00727.2010 · DOI · Paper page
- M Kato, 2009, MicroRNAs and their role in progressive kidney diseases, Clin J Am Soc Nephrol, 4, 1255, 10.2215/CJN.00520109 · DOI · Paper page
- JM Lorenzen, 2011, MicroRNAs as mediators and therapeutic targets in chronic kidney disease, Nat Rev Nephrol, 7, 286, 10.1038/nrneph.2011.26 · DOI · Paper page
- T Roweis, Sam, 1998, EM Algororithms for PCA and SPCA. Advances in Neural Information Processing Systems. Colorado, USA, 1997: The MIT Press, Vol, 10, 626
- W Stacklies, 2007, pcaMethods–a bioconductor package providing PCA methods for incomplete data, Bioinformatics, 23, 1164, 10.1093/bioinformatics/btm069 · DOI · Paper page
- RC Gentleman, 2004, Bioconductor: open software development for computational biology and bioinformatics, Genome Biol, 5, R80, 10.1186/gb-2004-5-10-r80 · DOI · Paper page
- MW Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, 29, e45, 10.1093/nar/29.9.e45 · DOI · Paper page
- Box GEP, Tiao GC (1973) Nature Of Bayesian Inference. Bayesian Inference In Statistical Analysis. Wiley Classics Library. 1–75.
- L Held, 2004, Simultaneous Posterior Probability Statements from Monte Carlo Output, Journal of Computational and Graphical Statistics, 13, 20, 10.1198/1061860043083 · DOI
- X Wang, 2008, Prediction of both conserved and nonconserved microRNA targets in animals, Bioinformatics, 24, 325, 10.1093/bioinformatics/btm595 · DOI · Paper page
- M Ashburner, 2000, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat Genet, 25, 25, 10.1038/75556 · DOI · Paper page
- G Wang, 2010, Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis, Am J Hypertens, 23, 78, 10.1038/ajh.2009.208 · DOI
- L Denby, 2011, miR-21 and miR-214 are consistently modulated during renal injury in rodent models, Am J Pathol, 179, 661, 10.1016/j.ajpath.2011.04.021 · DOI
- X-Y Bai, 2011, miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes, J Am Soc Nephrol, 22, 1252, 10.1681/ASN.2010040367 · DOI · Paper page
- G Wang, 2011, Serum and urinary free microRNA level in patients with systemic lupus erythematosus, Lupus, 20, 493, 10.1177/0961203310389841 · DOI · Paper page
- Y Dai, 2009, Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients, Rheumatol Int, 29, 749, 10.1007/s00296-008-0758-6 · DOI · Paper page
- G Wang, 2010, Expression of microRNAs in the urinary sediment of patients with IgA nephropathy, Dis Markers, 28, 79, 10.1155/2010/396328 · DOI · Paper page
- Lorenzen JM, Volkmann I, Fiedler J, Schmidt M, Scheffner I, <etal>et al</etal>.. (2011) Urinary miR-210 as a Mediator of Acute T-Cell Mediated Rejection in Renal Allograft Recipients. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Available:http://www.ncbi.nlm.nih.gov/pubmed/21812927. Accessed 25 September 2011. · DOI · Paper page
- AO Phillips, 1997, Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation, Kidney Int, 52, 973, 10.1038/ki.1997.419 · DOI
- SW Shan, 2009, MicroRNA MiR-17 retards tissue growth and represses fibronectin expression, Nat Cell Biol, 11, 1031, 10.1038/ncb1917 · DOI · Paper page
- M Hackl, 2010, miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging, Aging Cell, 9, 291, 10.1111/j.1474-9726.2010.00549.x · DOI · Paper page
- H Sun, 2010, MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation, Mol Biol Rep, 37, 2951, 10.1007/s11033-009-9861-3 · DOI
- U Tran, 2010, The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity, Development, 137, 1107, 10.1242/dev.046045 · DOI · Paper page
- J Hou, 2007, Transgenic RNAi Depletion of Claudin-16 and the Renal Handling of Magnesium, Journal of Biological Chemistry, 282, 17114, 10.1074/jbc.M700632200 · DOI · Paper page
- L Mahimainathan, 2006, Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN, Diabetes, 55, 2115, 10.2337/db05-1326 · DOI · Paper page
- Z Chun-Zhi, 2010, MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN, BMC Cancer, 10, 367, 10.1186/1471-2407-10-367 · DOI · Paper page
- S Fatima, 2012, Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model, Stem Cells, 30, 210, 10.1002/stem.1002 · DOI
- R Liao, 2008, MicroRNAs play a role in the development of human hematopoietic stem cells, J Cell Biochem, 104, 805, 10.1002/jcb.21668 · DOI · Paper page
- VA Valera, 2011, Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma, J Cancer, 2, 515, 10.7150/jca.2.515 · DOI
- P Dentelli, 2010, microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression, Arterioscler Thromb Vasc Biol, 30, 1562, 10.1161/ATVBAHA.110.206201 · DOI · Paper page
- G Togliatto, 2011, MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage, Diabetologia, 54, 1930, 10.1007/s00125-011-2125-5 · DOI
- G Ghosh, 2010, Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis, J Clin Invest, 120, 4141, 10.1172/JCI42980 · DOI · Paper page
- Chamorro-Jorganes A, Araldi E, Penalva LOF, Sandhu D, Fernández-Hernando C, <etal>et al</etal>.. (2011) MicroRNA-16 and MicroRNA-424 Regulate Cell-Autonomous Angiogenic Functions in Endothelial Cells via Targeting Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1. Arteriosclerosis, Thrombosis, and Vascular Biology. Available:http://www.ncbi.nlm.nih.gov/pubmed/21885851. Accessed 25 September 2011. · DOI · Paper page
- M Kato, 2007, MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors, Proc Natl Acad Sci USA, 104, 3432, 10.1073/pnas.0611192104 · DOI · Paper page
- M Kato, 2011, A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells, Kidney Int, 80, 358, 10.1038/ki.2011.43 · DOI · Paper page
- A Krupa, 2010, Loss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy, Journal of the American Society of Nephrology, 21, 438, 10.1681/ASN.2009050530 · DOI · Paper page
- D Macconi, 2012, MicroRNA-324-3p Promotes Renal Fibrosis and Is a Target of ACE Inhibition, JASN, 23, 1496, 10.1681/ASN.2011121144 · DOI
- O García-Sánchez, 2010, An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease, Kidney Int, 77, 950, 10.1038/ki.2010.88 · DOI
- Ostendorf T, Eitner F, Floege J (2011) The PDGF family in renal fibrosis. Pediatr Nephrol. Available:http://www.ncbi.nlm.nih.gov/pubmed/21597969. Accessed 4 September 2011.
- SM Titan, 2011, FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy, Clinical Journal of the American Society of Nephrology, 6, 241, 10.2215/CJN.04250510 · DOI
- K Heese, 2003, Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cells, Biochem Pharmacol, 65, 293, 10.1016/S0006-2952(02)01487-9 · doi:10.1016/s0006-2952(02)01487-9
- A Micera, 2001, Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair, Proc Natl Acad Sci USA, 98, 6162, 10.1073/pnas.101130898 · DOI · Paper page
- R Bonofiglio, 2007, Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys, J Nephrol, 20, 186
- D Shan, 2012, Pentoxifylline for diabetic kidney disease, Cochrane Database Syst Rev, 2, CD006800
- K Sharma, 2011, Pirfenidone for diabetic nephropathy, J Am Soc Nephrol, 22, 1144, 10.1681/ASN.2010101049 · DOI · Paper page
- P Ruggenenti, 2004, Preventing microalbuminuria in type 2 diabetes, N Engl J Med, 351, 1941, 10.1056/NEJMoa042167 · DOI · Paper page
- Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, <etal>et al</etal>.. (2011) MicroRNA Profiles in Allograft Tissues and Paired Urines Associate With Chronic Allograft Dysfunction With IF/TA. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Available:http://www.ncbi.nlm.nih.gov/pubmed/21794090. Accessed 25 September 2011. · DOI · Paper page
- Neal CS, Michael MZ, Pimlott LK, Yong TY, Li JYZ, <etal>et al</etal>.. (2011) Circulating microRNA expression is reduced in chronic kidney disease. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association. Available:http://www.ncbi.nlm.nih.gov/pubmed/21891774. Accessed 25 September 2011. · DOI · Paper page
- JA Weber, 2010, The microRNA spectrum in 12 body fluids, Clin Chem, 56, 1733, 10.1373/clinchem.2010.147405 · DOI · Paper page
Cited by
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Diabetic nephropathy – complications and treatment
Lim, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s40172 · Cited by 583
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages
Izumi, H., Tsuda, M., Sato, Y., Kosaka, N., Ochiya, T., Iwamoto, H., Namba, K., & Takeda, Y. (2015) · Journal of Dairy Science · doi:10.3168/jds.2014-9076 · Cited by 360
MicroRNAs in kidney physiology and disease
Trionfini, P., Benigni, A., & Remuzzi, G. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.202 · Cited by 353
Metadata
- Authors
- Argyropoulos, C., Wang, K., McClarty, S., Huang, D., Bernardo, J., Ellis, D., Orchard, T., Galas, D., & Johnson, J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-01-24
- Volume
- 8
- Issue
- 1
- Pages
- e54662
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1967550939
- Cited by
- 157
- References
- 8
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-08-08)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes. https://app.cochat.ai/papers/10.1371/journal.pone.0054662
- The paper
- Argyropoulos, C., Wang, K., McClarty, S., Huang, D., Bernardo, J., Ellis, D., Orchard, T., Galas, D., & Johnson, J. (2013). Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes. PLoS ONE. https://doi.org/10.1371/journal.pone.0054662
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.